RIBONOVA INC.

ribonova-inc-logo

RiboNova is a biopharmaceutical company in the Lankenau Institute for Medical Research near Philadelphia. The company is developing novel therapies for the treatment of serious rare diseases, including mitochondrial disease and certain cancers. RiboNova's drug discovery platform is targeting transfer RNA molecules.

#People #Financial #Website #More

RIBONOVA INC.

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2011-09-14

Address:
Wynnewood, Pennsylvania, United States

Country:
United States

Website Url:
http://www.ribonova.com

Total Employee:
1+

Status:
Active

Contact:
(610) 801-2541

Email Addresses:
[email protected]

Total Funding:
25 K USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business GStatic Google Static Content Google Cloud


Current Employees Featured

not_available_image

Anthony Ford-Hutchinson
Anthony Ford-Hutchinson Chief Scientific Officer @ RiboNova Inc.
Chief Scientific Officer

nigel-webb_image

Nigel Webb
Nigel Webb President and Chief Executive Officer @ RiboNova Inc.
President and Chief Executive Officer
2013-01-01

Founder


not_available_image

Anthony Ford-Hutchinson

nigel-webb_image

Nigel Webb

Investors List

bioadvance_image

BioAdvance

BioAdvance investment in Seed Round - RiboNova Inc.

Official Site Inspections

http://www.ribonova.com

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "RiboNova Inc."

RiboNova Inc. - Crunchbase Company Profile & Funding

RiboNova is a biopharmaceutical company in the Lankenau Institute for Medical Research near Philadelphia. The company is developing novel therapies for the treatment of serious rare …See details»

RiboNova Company Profile 2024: Valuation, Funding & Investors

Developer of small molecule drugs designed to treat serious rare diseases.See details»

RiboNova, Inc. - LinkedIn

RiboNova is a privately-held biopharmaceutical company based in the Lankenau Institute for Medical Research near Philadelphia, Pennsylvania. Our product pipeline includes a Phase-2 …See details»

RIBONOVA INC Company Profile | Wynnewood, PA - Dun

Find company research, competitor information, contact details & financial data for RIBONOVA INC of Wynnewood, PA. Get the latest business insights from Dun & Bradstreet.See details»

Ribonova Inc - Company Profile and News - Bloomberg Markets

Ribonova Inc was founded in 2011. The company's line of business includes the manufacturing, fabricating, and processing of drugs in pharmaceutical preparations for human and veterinary …See details»

RiboNova Inc. | Life Sciences PA - Default Site

RiboNova is a privately-held biopharmaceutical company based in the Lankenau Institute for Medical Research near Philadelphia, Pennsylvania. Our product pipeline includes a Phase-2 …See details»

Ribonova - Products, Competitors, Financials, Employees, …

Ribonova is a biopharmaceutical company focused on the discovery and development of novel medicines for serious rare diseases. Use the CB Insights Platform to explore Ribonova's full …See details»

RiboNova Inc. - Funding, Financials, Valuation & Investors

RiboNova is a biopharmaceutical company in the Lankenau Institute for Medical Research. near PhiladelphiaSee details»

RiboNova Inc. - Crunchbase

RiboNova is a biopharmaceutical company in the Lankenau Institute for Medical Research. near PhiladelphiaSee details»

Ribonova - Biotech Careers

RiboNova is a privately-held biopharmaceutical company based in the Lankenau Institute for Medical Research near Philadelphia, Pennsylvania.See details»

Nigel L. Webb - President, CEO & Board Member at …

Since Dr. Webb founded RiboNova, the National Institutes of Health has awarded Dr. Webb four peer-reviewed grants for his medical research into potential therapeutic applications of nucleic acid modifications.See details»

RiboNova - BioAdvance

RiboNova Inc. Developing small molecule drugs against a new family of targets, defective transfer RNAs. Its focus is on therapies that will be used in the treatment of cancer. Active Portfolio …See details»

Anthony W. Ford-Hutchinson - The Org

Chief Scientific Officer & Board Member at Ribonova Contact Tony Ford-Hutchinson has substantial experience with pharmaceuticals, drug and vaccines discovery, research and …See details»

tRNA Drug (RiboNova) - Drug Targets, Indications, Patents - Synapse

Understand key drug designations in just a few clicks with Synapse. tRNA Drug (RiboNova), Initially developed by RiboNova, Inc., Now, its global highest R&D status is Discovery, …See details»

RiboNova Inc. - Contacts, Employees, Board Members

RiboNova is a biopharmaceutical company in the Lankenau Institute for Medical Research. near PhiladelphiaSee details»

Robert T. Sarisky - Board Member at Ribonova | The Org

As an entrepreneurial executive and Board Member with over 30 years of expertise in the pharmaceutical and biotechnology industry, Rob has contributed to the advancement of …See details»

Nigel Webb - President and Chief Executive Officer @ RiboNova …

Since Dr. Webb founded RiboNova, the National Institutes of Health has awarded Dr. Webb three peer-reviewed grants for his medical research into potential therapeutic applications of nucleic …See details»

Ribonova - CB Insights

Explore {Ribonova's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Marni J. Falk - Scientific Advisor at Ribonova - The Org

She works to improve precision clinical care, diagnostic approaches, and genomic resources for mitochondrial disease, including the organization of the global Mitochondrial Disease …See details»

The Pursuit of Precision Mitochondrial Medicine: Harnessing pre ...

MJF is a co-founder of MitoCUREia, Inc, scientific advisory board member with equity interest in RiboNova, Inc., and scientific board member as paid consultant with Khondrion (active) and …See details»

linkstock.net © 2022. All rights reserved